Integer (ITGR) to Release Earnings on Thursday

Integer (NYSE:ITGR) will issue its quarterly earnings data before the market opens on Thursday, October 24th. Analysts expect the company to announce earnings of $1.36 per share for the quarter. Integer has set its FY24 guidance at $5.07-5.49 EPS and its FY 2024 guidance at 5.070-5.490 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. The company had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. Integer’s revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.14 EPS. On average, analysts expect Integer to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Integer Stock Performance

Shares of ITGR stock opened at $131.06 on Thursday. The firm’s 50 day moving average is $126.20 and its 200 day moving average is $120.41. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $4.39 billion, a P/E ratio of 45.35, a PEG ratio of 1.86 and a beta of 1.08. Integer has a 12 month low of $69.40 and a 12 month high of $133.53.

Insider Transactions at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on ITGR shares. Benchmark reaffirmed a “buy” rating and set a $130.00 target price on shares of Integer in a report on Wednesday, October 2nd. Oppenheimer started coverage on shares of Integer in a report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price on the stock. Bank of America upped their target price on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. KeyCorp upped their target price on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a report on Tuesday. Finally, Truist Financial upped their target price on shares of Integer from $145.00 to $150.00 and gave the stock a “buy” rating in a report on Monday. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $138.71.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.